Our data and insights help accelerate innovation and adoption
Life sciences leaders trust our robust real-world data and experienced consultants to connect the dots in ways that answer tough questions, illuminate new possibilities and improve patients’ lives.
Frost & Sullivan names Optum Life Sciences Company of the Year
Frost & Sullivan’s top honor recognizes visionary innovation, market-leading performance and unmatched customer care. We are humbled and grateful to accept this award in the field of North American real-world evidence and IT solutions for the health care industry.
Solutions for life sciences companies
From data to insight to action, we catalyze clinical innovation
Cutting-edge, enriched data. Unparalleled security and support.
Generate evidence with real-world data.
Gain greater insights through clinicogenomics.
Empower commercial, brand and market access teams.
Expert teams who know how to solve your trickiest problems
Strengthen your value story with HEOR.
Engage payers with value-based contracts.
Partner with our epidemiology consultants.
Narrow the gap between ideas and impact
Design, pilot and scale engagement programs.
Enhance clinical trial design and performance.
Find patients and streamline clinical trials.
The 7 trends shaping life sciences strategies in 2023
Optum and Advisory Board market experts come together to give their take on the key trends that will shape life sciences strategies in 2023.
Latest from Optum Life Sciences
Clinicogenomics: New data advances life sciences research
The study of clinicogenomics is helping researchers unlock novel insights to guide drug discovery, development and commercialization.
Article
Learn how a pilot was designed to help patients with hyperlipidemia.
Videos
Learn about forward-thinking strategies from cross-industry experts.
Podcast
Hear how Optum supported the FDA by analyzing COVID-19 vaccine safety.
Cross-industry conversations featuring Optum experts
Inside the science of genetics and genomics by STAT
Explore the evolving research into human genetics and genomics, the promise of gene therapies, and the questions faced in the years ahead.
Inform population-level care with RWD and RWE
Optum and Amgen experts share best practices for using RWD to address questions across the clinical and drug development life cycle.
RWE is critical to the whole health care ecosystem
Lou Brooks, SVP of Real-World Data and Analytics, joins the Radio Advisory podcast to talk about the evolving world of clinical evidence.